Monoclonal antibodies (mAbs) deliver great benefits to patients with chronic and/or severe diseases thanks to their strong specificity to the therapeutic target. As a result of this specificity. non-human primates (NHP) are often the only preclinical species in which therapeutic antibodies cross-react with the target. Here. https://www.freaknleather.com/product-category/tig-foot-control/